Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy

By Andre V.   Ferrandon A.   Marescaux C.   Nehlig A.  

Epilepsy Research, Vol. 47, Iss. 1, 2001-11 ,pp. : 99-117

Elsevier

Access to resources Recommend Favorite

Relationship between Neuronal Loss and Interictal Glucose Metabolism during the Chronic Phase of the Lithium-Pilocarpine Model of Epilepsy in the Immature and Adult Rat

By Dube C.   Boyet S.   Marescaux C.   Nehlig A.  

Experimental Neurology, Vol. 167, Iss. 2, 2001-02 ,pp. : 227-241

Elsevier

Access to resources Recommend Favorite

The course of untreated seizures in the pilocarpine model of epilepsy

By Arida R.M.   Scorza F.A.   de Araujo Peres C.   Cavalheiro E.A.  

Epilepsy Research, Vol. 34, Iss. 2, 1999-04 ,pp. : 99-107

Elsevier

Access to resources Recommend Favorite

Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model

By Borges K.   Gearing M.   McDermott D.L.   Smith A.B.   Almonte A.G.   Wainer B.H.   Dingledine R.  

Experimental Neurology, Vol. 182, Iss. 1, 2003-07 ,pp. : 21-34

Elsevier

Access to resources Recommend Favorite

In the lithium-pilocarpine model of epilepsy, brain lesions are not linked to changes in blood-brain barrier permeability: an autoradiographic study in adult and developing rats

By Leroy C.   Roch C.   Koning E.   Namer I.J.   Nehlig A.  

Experimental Neurology, Vol. 182, Iss. 2, 2003-08 ,pp. : 361-372

Elsevier

Access to resources Recommend Favorite